Filing Details
- Accession Number:
- 0001209191-23-030244
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-17 16:51:06
- Reporting Period:
- 2023-05-15
- Accepted Time:
- 2023-05-17 16:51:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1358762 | Reata Pharmaceuticals Inc | RETA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1034320 | D Michael Wortley | 5320 Legacy Drive Plano TX 75024 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2023-05-15 | 894 | $84.81 | 47,198 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2023-05-16 | 417 | $80.99 | 46,781 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.